IndraLab

Statements


IRF9 inhibits USP18. 1 / 1
| 1

reach
"Low dose IFNα increases baseline STAT2 and IRF9 expression without strongly activating the negative feedback regulators SOCS1, SOCS3, and USP18, thereby hypersensitizing cells to further interferon stimulation (26)."